Form: SC 13D

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

March 10, 2008

 

Exhibit 1
JOINT FILING AGREEMENT
     Each of the undersigned agrees that (i) the statement on Schedule 13D relating to the Common Stock of Opko Health, Inc., has been adopted and filed on behalf of each of them, (ii) all future amendments to such statement on Schedule 13D will, unless written notice to the contrary is delivered as described below, be jointly filed on behalf of each of them, and (iii) the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934 apply to each of them. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13D as to any of the undersigned upon such person giving written notice thereof to each of the other persons signature hereto, at the principal office thereof.
     This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Date: March 5, 2008
Psilos Group Partners II-S, L.P.
By: Psilos Group Investors II-S, L.L.C., its General Partner
         
By:
Name:
  /s/ Jeffrey M. Krauss
 
Jeffrey M. Krauss
   
Title:
  Managing Member    
Psilos Group Investors II-S, L.L.C.
         
By:
Name:
  /s/ Jeffrey M. Krauss
 
Jeffrey M. Krauss
   
Title:
  Managing Member    
Psilos Group Managers, LLC
         
By:
Name:
  /s/ Jeffrey M. Krauss
 
Jeffrey M. Krauss
   
Title:
  Managing Member